Tohru Takeuchi

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Topics

Rheumatoid Arthritis

Pulmonary Arterial Hypertension

Interstitial Lung Disease

Top Venues

Rheumatology international

Rheumatology advances in practice

Rheumatology (Oxford, England)

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Hideaki Sofue, Takashi Kida, Aiko Hirano, Satoshi Omura, Masatoshi Kadoya, Daiki Nakagomi, Yoshiyuki Abe, Naoho Takizawa, Atsushi Nomura, Yuji Kukida, Naoya Kondo, Yasuhiko Yamano, Takuya Yanagida, Koji Endo, Shintaro Hirata, Kiyoshi Matsui, Tohru Takeuchi, Kunihiro Ichinose, Masaru Kato, Ryo Yanai, Yusuke Matsuo, Yasuhiro Shimojima, Ryo Nishioka, Ryota Okazaki, Tomoaki Takata, Takafumi Ito, Mayuko Moriyama, Ayuko Takatani, Yoshia Miyawaki, Toshiko Ito-Ihara, Nobuyuki Yajima, Takashi Kawaguchi, Kazuki Fujioka, Wataru Fujii, Takahiro Seno, Makoto Wada, Masataka Kohno, Yutaka Kawahito
Optimal Dose of Intravenous Cyclophosphamide during remission induction therapy in ANCA-associated vasculitis: a retrospective cohort study of J-CANVAS. Modern rheumatology (2023)
Kenichiro Hata, Takuya Kotani, Shogo Matsuda, Youhei Fujiki, Takayasu Suzuka, Takao Kiboshi, Yumiko Wada, Hideyuki Shiba, Takeshi Shoda, Maki Kagitani, Tohru Takeuchi
Aggressive multi-combination therapy for anti-MDA5 antibody-positive dermatomyositis-rapidly progressive interstitial lung disease. International journal of rheumatic diseases (2023)
Katsumasa Oe, Shogo Matsuda, Takuya Kotani, Tohru Takeuchi
Comment on: Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD. Rheumatology (Oxford, England) 61 (12) (2022)
Shogo Matsuda, Mahiro Yamamoto, Takuya Kotani, Tohru Takeuchi
Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. Rheumatology advances in practice 6 (1) (2022)
Shogo Matsuda, Mahiro Yamamoto, Takuya Kotani, Tohru Takeuchi
Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. Reply. Rheumatology advances in practice 6 (1) (2022)
Shogo Matsuda, Takuya Kotani, Tohru Takeuchi
Comment on: Intravenous immunoglobulin for interstitial lung diseases of anti-melanoma differentiation-associated gene 5-positive dermatomyositis. Rheumatology (Oxford, England) 61 (9) (2022)
Shogo Matsuda, Takuya Kotani, Hiroko Kuwabara, Takayasu Suzuka, Takao Kiboshi, Yumiko Wada, Takaaki Ishida, Youhei Fujiki, Hideyuki Shiba, Kenichiro Hata, Takeshi Shoda, Yoshinobu Hirose, Tohru Takeuchi
Association of M2 Macrophages, Th2, and B Cells With Pathomechanism in Microscopic Polyangiitis Complicated by Interstitial Lung Disease. The Journal of rheumatology 49 (8) (2022)
Takaaki Ishida, Shuzo Yoshida, Youhei Fujiki, Kenichiro Hata, Takuya Kotani, Tohru Takeuchi
Effects of denosumab on rheumatic diseases and refractory glucocorticoid-induced osteoporosis: a prospective study. Archives of osteoporosis 16 (1) (2021)
Kosuke Ebina, Toru Hirano, Yuichi Maeda, Wataru Yamamoto, Motomu Hashimoto, Koichi Murata, Akira Onishi, Sadao Jinno, Ryota Hara, Yonsu Son, Hideki Amuro, Tohru Takeuchi, Ayaka Yoshikawa, Masaki Katayama, Keiichi Yamamoto, Makoto Hirao, Yasutaka Okita, Atsushi Kumanogoh, Ken Nakata
Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study. Clinical rheumatology 40 (7) (2021)
Kosuke Ebina, Toru Hirano, Yuichi Maeda, Wataru Yamamoto, Motomu Hashimoto, Koichi Murata, Tohru Takeuchi, Koji Nagai, Yonsu Son, Hideki Amuro, Akira Onishi, Sadao Jinno, Ryota Hara, Masaki Katayama, Keiichi Yamamoto, Atsushi Kumanogoh, Makoto Hirao
Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study. Clinical rheumatology 39 (9) (2020)
Sadao Jinno, Akira Onishi, M Hassan Murad, Kengo Akashi, Motomu Hashimoto, Wataru Yamamoto, Koichi Murata, Tohru Takeuchi, Takuya Kotani, Yuichi Maeda, Kosuke Ebina, Yonsu Son, Hideki Amuro, Ryota Hara, Masaki Katayama, Jun Saegusa, Akio Morinobu
Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study. Rheumatology international 40 (12) (2020)
Koichi Murata, Motomu Hashimoto, Wataru Yamamoto, Yonsu Son, Hideki Amuro, Koji Nagai, Tohru Takeuchi, Masaki Katayama, Yuichi Maeda, Kosuke Ebina, Ryota Hara, Sadao Jinno, Akira Onishi, Kosaku Murakami, Masao Tanaka, Hiromu Ito, Tsuneyo Mimori, Shuichi Matsuda
The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study. Rheumatology international 40 (2) (2019)
Shogo Matsuda, Shuzo Yoshida, Youhei Fujiki, Hidetoshi Satomi, Tohru Takeuchi, Yoshinobu Hirose, Shigeki Makino, Shigeki Arawaka
Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature. Rheumatology international 38 (4) (2017)